genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2013
Spinal muscular atrophy
Best of the Web
Learn About Spinal Muscular Atrophy
News
Biogen Idec Pays Isis $3.5M for Antisense Drug Milestone
News
Repligen, Pfizer Make $70M Spinal Muscular Atrophy Deal
News
Funds Awarded for MS Drug Clinical Trial
News
Biogen Idec Pays Isis $12M in Antisense Drug Deal
News
Retrophin Takes on Ligand’s Nephropathy Candidate DARA for $1M Up Front
News
Biogen Idec Pays Isis $29M for Option to Early-Clinical SMA Antisense Therapy
Drug Discovery
Roche Nabs PTC’s SMA Program for $30M Up Front
News
Antisense Therapy Improves Lifespan and Motor Function in Mice with Severe Spinal Muscular Atrophy
News
Muscular Dystrophy Association Makes $13.7M Available to 40 Research Programs
1
...
3
4
5
6
Page 4 of 6
Scroll Up
Scroll Up
